Tyra Biosciences, Inc.
TYRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $80 | $63 | $43 | $21 |
| G&A Expenses | $24 | $17 | $16 | $6 |
| SG&A Expenses | $24 | $17 | $16 | $6 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $104 | $80 | $59 | $26 |
| Operating Income | -$104 | -$80 | -$59 | -$26 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $18 | $11 | $4 | -$0 |
| Pre-Tax Income | -$86 | -$69 | -$55 | -$26 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$86 | -$69 | -$55 | -$26 |
| % Margin | – | – | – | – |
| EPS | -1.51 | -1.62 | -1.23 | -0.63 |
| % Growth | 6.8% | -31.7% | -95.2% | – |
| EPS Diluted | -1.51 | -1.62 | -1.23 | -0.63 |
| Weighted Avg Shares Out | 57 | 43 | 42 | 41 |
| Weighted Avg Shares Out Dil | 57 | 43 | 42 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $18 | $11 | $4 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $0 | $0 | $0 |
| EBITDA | -$104 | -$80 | -$59 | -$26 |
| % Margin | – | – | – | – |